Abstract

This study aimed to investigate the effects of grape seed proanthocyanidin extract (GSPE) on blood pressure and vascular endothelial function in middle-aged Japanese adults with prehypertension. We conducted a randomized, double-blind, placebo-controlled study on 6 men and 24 women aged 40–64 years old. The participants were randomized to receive tablets containing either low-dose (200 mg/day) or high-dose (400 mg/day) GSPE, or placebo, for 12 weeks. Systolic and diastolic blood pressures (SBP and DBP, respectively), brachial flow-mediated dilation (FMD), and other cardiovascular parameters were measured before and after 4, 8, and 12 weeks of treatment. The mean SBP in the high-dose group significantly decreased by 13 mmHg after 12 weeks (P = 0.028), although FMD did not change. In an ad hoc analysis of non-smoking participants (n = 21), the mean SBP, DBP, stiffness parameter β, distensibility, incremental elastic modulus (Einc), and pulse wave velocity (PWV) also significantly improved in the high-dose group after 12 weeks. Changes in Einc and PWV from baseline to 12 weeks were significantly greater in the high-dose group than in the placebo group (Einc, P = 0.023; PWV, P = 0.03). GSPE consumption could help maintain vascular elasticity and normal blood pressure in this population.

Highlights

  • Hypertension is one of the major risk factors for cardiovascular diseases (CVDs), which are a leading cause of global mortality

  • The present study aimed to investigate the effects of grape seed proanthocyanidin extract (GSPE) on blood pressure (BP) and endothelial functions, as assessed by Flow-mediated dilation (FMD), in middle-aged Japanese men and women with prehypertension

  • In some recruited participants who met the pre-defined criteria for prehypertension at the time of enrollment, the mean Systolic blood pressure (SBP) and Diastolic blood pressure (DBP) at baseline were within the hypertensive range

Read more

Summary

Introduction

Hypertension is one of the major risk factors for cardiovascular diseases (CVDs), which are a leading cause of global mortality. 16.5% of the total mortality, and the global prevalence of hypertension in adults aged 18 years old or older was approximately 22.3% in 2015 [1,2]. Endothelial function impairment has been shown to play a key role in the early stages of atherosclerosis [3,4], linking cardiovascular risk factors, such as hypertension, dyslipidemia, diabetes mellitus, and chronic smoking, to endothelial dysfunction [5,6]. The preservation of normal endothelial function and regulation of BP are crucial to preventing progression to CVDs. Nutrients 2019, 11, 2844; doi:10.3390/nu11122844 www.mdpi.com/journal/nutrients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call